On the recordJanuary 28, 2020
Simply put, extending orphan drug designation in this manner would have been inconsistent with the intention of the Orphan Drug Act.
Source
congress.govEditor's note · Context
Blunt Rochester argues against orphan drug designation for profitable treatments.
Share
More from Lisa Blunt Rochester
Jun 19, 2026
Our doctors, nurses, and support staff are the best of Delaware. They hold us together in our darkest hours.
May 27, 2026
As a mother and grandmother, I know first-hand the joys and challenges that motherhood brings.
Jun 20, 2026
Americans are struggling with rising prices across the board while reliable domestic manufacturing jobs are moving overseas.
Jun 21, 2026
Today, it is on us to be strong for them in their time of pain and grief. Our hearts are with the families of the victims and the Wilmington Hospital community.
Other voices in this conversation
